Metsera, Inc.Metsera, Inc.Metsera, Inc.

Metsera, Inc.

No trades
See on Supercharts

MTSR fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Metsera, Inc. is a clinical stage biopharmaceutical company, which engages in the development of a next-generation injectable and oral nutrient stimulated hormone, or NuSH, analog peptides to treat obesity, overweight and related conditions. Its product pipeline includes MET-097i, MET-233, and MET-224o. The company was founded by Clive A. Meanwell on June 29, 2022 and is headquartered in New York, NY.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
MTSR has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company